Cargando…
A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet’s Syndrome
Thrombosis is common in Behçet’s Syndrome (BS), and there is a need for better biomarkers for risk assessment. As microparticles expressing Tissue Factor (TF) can contribute to thrombosis in preclinical models, we investigated whether plasma microparticles expressing Tissue Factor (TF) are increased...
Autores principales: | Khan, E., Ambrose, N. L., Ahnström, J., Kiprianos, A. P., Stanford, M. R., Eleftheriou, D., Brogan, P.A., Mason, J. C., Johns, M., Laffan, M. A., Haskard, D. O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141484/ https://www.ncbi.nlm.nih.gov/pubmed/27924945 http://dx.doi.org/10.1038/srep38104 |
Ejemplares similares
-
Paediatric Behçet’s disease: a UK tertiary centre experience
por: Nanthapisal, Sira, et al.
Publicado: (2016) -
PReS-FINAL-2363: Behçet's disease in children: the Great Ormond Street Hospital experience
por: Nanthapisal, S, et al.
Publicado: (2013) -
Tissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis?
por: Woei-A-Jin, F J Sherida H, et al.
Publicado: (2016) -
Behçet’s Syndrome
por: Pickering, Matthew C, et al.
Publicado: (2000) -
Behçet’s Syndrome and Thrombosis
por: Seyahi, Emire, et al.
Publicado: (2011)